Beautiful Virgin Islands

Saturday, Jul 26, 2025

STUDY: AstraZeneca booster dose significantly neutralises Omicron

STUDY: AstraZeneca booster dose significantly neutralises Omicron

British pharmaceutical giant AstraZeneca has revealed that a third, or ‘booster’ dose of its COVID-19 vaccine significantly lifted antibody levels against the Omicron variant.

This is based on a recent laboratory study whose findings suggest that AstraZeneca’s vaccine and its preventative monoclonal antibody treatment, Evusheld, “retains neutralisation activity” against Omicron.

“The third dose booster vaccination neutralised the Omicron variant to levels that were broadly similar to those observed… after the second dose against the Delta variant,” AstraZeneca said in a statement.

According to the statement, the levels at which antibodies became neutralised from the booster jab were also higher in individuals who had previously been infected and recovered naturally.

Meanwhile, the study was conducted by investigators from the University of Oxford, which is the academic institution that helped AstraZeneca develop the vaccine last year.

Researchers also analysed blood samples taken from individuals infected with COVID-19 as well as those vaccinated with a booster and those who had reported the a previous COVID infection.

“It is very encouraging to see that current vaccines have the potential to protect against Omicron following a third dose booster. These results support the use of third dose boosters as part of national vaccine strategies, especially to limit the spread of variants of concern, including Omicron,” said University of Oxford professor John Bell, one of the researchers.

Pfizer to become the vaccine of choice for BVI


While AstraZeneca has revealed this finding, the Ministry of Health here in the BVI that announced Pfizer will become the vaccine of choice in the territory as it expects the supply ability of AstraZeneca to dwindle in the new year.

The Acting Chief Medical Officer (CMO) Dr Ronald Georges said Oxford University in the UK carried out a large trial to determine which vaccines would be most effective as boosters overall and the results showed mRNA vaccines such as Pfizer would be best.

Dr Georges also announced that persons who have completed their primary vaccination with the two-dose regimen like AstraZeneca can receive the Pfizer booster three months after completion of their last dose.

Earlier this month, the ministry received 4,680 doses of the Pfizer vaccine from the United Kingdom and more are expected to become available in January.

Newsletter

Related Articles

Beautiful Virgin Islands
0:00
0:00
Close
Deputy attorney general's second day of meeting with Ghislaine Maxwell has concluded
Controversial March in Switzerland Features Men Dressed in Nazi Uniforms
Politics is a good business: Barack Obama’s Reported Net Worth Growth, 1990–2025
Thai Civilian Death Toll Rises to 12 in Cambodian Cross-Border Attacks
TSUNAMI: Trump Just Crossed the Rubicon—And There’s No Turning Back
Over 120 Criminal Cases Dismissed in Boston Amid Public Defender Shortage
UN's Top Court Declares Environmental Protection a Legal Obligation Under International Law
"Crazy Thing": OpenAI's Sam Altman Warns Of AI Voice Fraud Crisis In Banking
The Podcaster Who Accidentally Revealed He Earns Over $10 Million a Year
Trump Announces $550 Billion Japanese Investment and New Trade Agreements with Indonesia and the Philippines
US Treasury Secretary Calls for Institutional Review of Federal Reserve Amid AI‑Driven Growth Expectations
UK Government Considers Dropping Demand for Apple Encryption Backdoor
Severe Flooding in South Korea Claims Lives Amid Ongoing Rescue Operations
Japanese Man Discovers Family Connection Through DNA Testing After Decades of Separation
Russia Signals Openness to Ukraine Peace Talks Amid Escalating Drone Warfare
Switzerland Implements Ban on Mammography Screening
Japanese Prime Minister Vows to Stay After Coalition Loses Upper House Majority
Pogacar Extends Dominance with Stage Fifteen Triumph at Tour de France
CEO Resigns Amid Controversy Over Relationship with HR Executive
Man Dies After Being Pulled Into MRI Machine Due to Metal Chain in New York Clinic
NVIDIA Achieves $4 Trillion Valuation Amid AI Demand
US Revokes Visas of Brazilian Corrupted Judges Amid Fake Bolsonaro Investigation
U.S. Congress Approves Rescissions Act Cutting Federal Funding for NPR and PBS
North Korea Restricts Foreign Tourist Access to New Seaside Resort
Brazil's Supreme Court Imposes Radical Restrictions on Former President Bolsonaro
Centrist Criticism of von der Leyen Resurfaces as she Survives EU Confidence Vote
Judge Criticizes DOJ Over Secrecy in Dropping Charges Against Gang Leader
Apple Closes $16.5 Billion Tax Dispute With Ireland
Von der Leyen Faces Setback Over €2 Trillion EU Budget Proposal
UK and Germany Collaborate on Global Military Equipment Sales
Trump Plans Over 10% Tariffs on African and Caribbean Nations
Flying Taxi CEO Reclaims Billionaire Status After Stock Surge
Epstein Files Deepen Republican Party Divide
Zuckerberg Faces $8 Billion Privacy Lawsuit From Meta Shareholders
FIFA Pressured to Rethink World Cup Calendar Due to Climate Change
SpaceX Nears $400 Billion Valuation With New Share Sale
Microsoft, US Lab to Use AI for Faster Nuclear Plant Licensing
Trump Walks Back Talk of Firing Fed Chair Jerome Powell
Zelensky Reshuffles Cabinet to Win Support at Home and in Washington
"Can You Hit Moscow?" Trump Asked Zelensky To Make Putin "Feel The Pain"
Irish Tech Worker Detained 100 days by US Authorities for Overstaying Visa
Dimon Warns on Fed Independence as Trump Administration Eyes Powell’s Succession
Church of England Removes 1991 Sexuality Guidelines from Clergy Selection
Superman Franchise Achieves Success with Latest Release
Hungary's Viktor Orban Rejects Agreements on Illegal Migration
Jeff Bezos Considers Purchasing Condé Nast as a Wedding Gift
Ghislaine Maxwell Says She’s Ready to Testify Before Congress on Epstein’s Criminal Empire
Bal des Pompiers: A Celebration of Community and Firefighter Culture in France
FBI Chief Kash Patel Denies Resignation Speculations Amid Epstein List Controversy
Air India Pilot’s Mental Health Records Under Scrutiny
×